Ivermectin In Treatment of COVID 19 Patients

Kamal et al., NCT04425707, NCT04425707, Sep 2020

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.
Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective.
Protocols combine treatments.

6,700+ studies · 220+ treatments

c19early.org
Meta-analysis
Estimated 100 patient ivermectin early treatment RCT with results not reported over 6 years after estimated completion.
3 ivermectin RCTs have results missing long after expected1-3
The trials report an estimated total of 912 patients.
Important missing comments or errors? Let us know.
Kamal et al., 1 Sep 2020, Randomized Controlled Trial, trial NCT04425707 (history).
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0